# To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

> **NCT00865670** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 38 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Azithromycin Monohydrate 600 mg Tablets
- **DRUG:** Zithromax (azithromycin dihydrate) 600 mg Tablets

## Key facts

- **NCT ID:** NCT00865670
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865670, "To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00865670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*